From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

The partnership, which began in December 2022, now provides AbbVie access to AbCellera’s TCE platform for the development of therapeutic antibodies targeting tumours. AbbVie will have the rights ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

A review of recent trends and remaining challenges in bispecific antibody (bsAb) production has been published.

The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Dr Jörg Schüttrumpf, Grifols Chief Scientific Innovation Officer, stated: “Grifols is excited to contribute its deepening knowledge of therapeutic antibody development, including recombinants, to FcR ...

In this article, we are going to take a look at where ImmunoPrecise Antibodies Ltd. (NASDAQ ... said that the company anticipates enabling the development of three key robots in the coming years ...

A new study shows how an anticancer drug triggers an "outside in" signal that gets it sucked into a cancer cell. The work, ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...